LOADING
Comparing Johnson & Johnson (JNJ) and AbbVie Inc (ABBV), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $415.0B |
| P/E Ratio | -- | 115.1 |
| Forward P/E | -- | 16.5 |
| PEG Ratio | -- | 0.65 |
| EPS | -- | $2.04 |
| Revenue Growth (YoY) | -- | 12.4% |
| Profit Margin | -- | 5.8% |
| Return on Equity | -- | 62.3% |
| Dividend Yield | -- | 2.87% |
| Beta | -- | 0.31 |
| 52-Week High | -- | $244.58 |
| 52-Week Low | -- | $176.00 |
| Volume | -- | -- |